Overview

Study of Different Forms of Danicopan (Tablet, Softgel Capsule, Liquid-filled Capsule) in Healthy Participants

Status:
Completed

Trial end date:
2016-10-05

Target enrollment:

Participant gender:

Summary

This was a randomized, crossover, open-label study to assess the relative bioavailability, pharmacokinetics (PK), and safety of three different formulations of danicopan (tablet, softgel capsule, liquid-filled capsule [LFC]) in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Alexion Pharmaceuticals

Collaborator:

Achillion, a wholly owned subsidiary of Alexion